Exagen Inc. XGN Deferred Tax Liabilities
Deferred Tax Liabilities at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilities.
The official record: Exagen Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s deferred tax liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s deferred tax liabilities?
- Exagen Inc. (XGN) reported deferred tax liabilities of $1.18M in Q4 2025.
- How has Exagen Inc.'s deferred tax liabilities changed year-over-year?
- Exagen Inc.'s deferred tax liabilities increased by 66.7% year-over-year, from $708K to $1.18M.
- What is the long-term trend for Exagen Inc.'s deferred tax liabilities?
- Over 5 years (2020 to 2025), Exagen Inc.'s deferred tax liabilities has grown at a 8.2% compound annual growth rate (CAGR), from $795K to $1.18M.
- What does deferred tax liabilities mean?
- Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.